Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TFFP

TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TFFP
일자시간출처헤드라인심볼기업
2024/05/1805:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
2024/05/1805:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2024/05/1505:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2024/05/1505:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
2024/05/0713:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/1920:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/1606:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/1314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/0906:52Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/0906:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/0507:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/0507:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/12/0507:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/11/2307:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/11/2206:41Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
2023/11/1506:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/10/0505:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/10/0505:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/10/0505:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/09/2305:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/09/1906:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/09/1905:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1805:01GlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1705:43Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1521:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1521:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1519:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1519:00GlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1505:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
2023/08/1505:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:TFFP